![SK bioscience CEO Ahn Jae-yong, second from left, speaks during the Regionalised Vaccine Manufacturing Collaborative event held on Monday in Geneva, Switzerland. [SK BIOSCIENCE]](https://koreajoongangdaily.joins.com/data/photo/2023/05/23/b09c9769-9dc6-4118-a4bf-eae338c709eb.jpg)
SK bioscience introduced its “glocalization” project aimed at ensuring equitable access to vaccines, during the Regionalised Vaccine Manufacturing Collaborative (RVMC) in Switzerland, the pharmaceutical company said Tuesday.
The RVMC is an international framework kicked off during the World Economic Forum in Davos in May last year, with the goal of resolving inequality in the vaccine supply.
Ahn Jae-yong, SK bioscience CEO, introduced the company’s glocalization project, which is one of the company’s new business strategies. The project aims to establish local production facilities in regions with limited accessibility to vaccines, by transferring production capabilities, technologies and expertise to local authorities or companies.
The RVMC event was held in Geneva, Switzerland, during the 76th World Health Assembly, which runs from Sunday, May 21 to May 30.
BY SHIN HA-NEE [shin.hanee@joongang.co.kr]

![Korean American nonprofits hit hard by federal funding cuts The KHEIR Clinic held its annual Holiday Winter Festival on December 6 in the clinic’s parking lot. What began as a toy-drive event has grown each year into one of the neighborhood’s signature year-end festivals, drawing more than 1,000 participants this year. [Sangjin Kim, The Korea Daily]](https://www.koreadailyus.com/wp-content/uploads/2025/12/1209-Kheir-100x70.jpg)

![Koreatown school enrollment shows steepest decline in LAUSD The number of students at schools across Koreatown in Los Angeles is sharply declining. Recruitment banners hang on the exterior walls of an elementary school. [Sangjin Kim, The Korea Daily]](https://www.koreadailyus.com/wp-content/uploads/2025/12/1208-schools-100x70.jpg)
